Rectal Cancer Clinical Trial
— SpeeDyOfficial title:
Randomized Non-inferiority Trial of Selective Splenic Flexure Mobilization for the Formation of Low Colorectal Anastomosis After Total Mesorectal Excision and D3 Paraaortic Lymph Node Dissection in Low Rectal Cancer.
In the Low Anterior Resection of rectum for cancer, the section level of IMA and the need of
SFM is still debated.
The aim of this study is to explore the different impacts of high and low ligation with
peeling off vascular sheath of inferior mesenteric artery (IMA) in low anterior resection of
the rectum for cancer. This study purpose to demonstrate that low IMA ligation, sparing of
left colic artery (LCA) and selective SFM results in higher anastomotic leakage rate than
high IMA ligation with routine SFM (with the difference of more than 5%).
| Status | Recruiting |
| Enrollment | 142 |
| Est. completion date | November 2, 2021 |
| Est. primary completion date | May 2, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 85 Years |
| Eligibility |
Inclusion Criteria: 1. Histologically proven primary rectal adenocarcinoma located within 15 cm from anal verge not involving internal and/or external sphincter muscle 2. Stage I-III 3. Elective surgical treatment with TME and primary colorectal anastomosis 4. Receive or not receive neoadjuvant radio-chemotherapy 5. Overall health status according to American Society of Anesthesiologists (ASA) classification: I-III 6. Signed informed consent with agreement to attend all study visits 7. The patient is not pregnant Exclusion Criteria: 1. Unresectable tumour, inability to perform a TME with colorectal anastomosis, inability to complete R0 resection or presence of T4b tumour necessitating a multi-organ resection 2. The patient wants to withdraw from the clinical trial 3. Loss to follow-up 4. Inability to complete all the trial procedures |
| Country | Name | City | State |
|---|---|---|---|
| Russian Federation | Clinic of Colorectal and Minimally Invasive Surgery | Moscow |
| Lead Sponsor | Collaborator |
|---|---|
| Russian Society of Colorectal Surgeons |
Russian Federation,
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986 Jun 28;1(8496):1479-82. — View Citation
Ho YH. Techniques for restoring bowel continuity and function after rectal cancer surgery. World J Gastroenterol. 2006 Oct 21;12(39):6252-60. Review. — View Citation
Kanemitsu Y, Hirai T, Komori K, Kato T. Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery. Br J Surg. 2006 May;93(5):609-15. — View Citation
Katory M, Tang CL, Koh WL, Fook-Chong SM, Loi TT, Ooi BS, Ho KS, Eu KW. A 6-year review of surgical morbidity and oncological outcome after high anterior resection for colorectal malignancy with and without splenic flexure mobilization. Colorectal Dis. 20 — View Citation
Lange MM, Buunen M, van de Velde CJ, Lange JF. Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum. 2008 Jul;51(7):1139-45. doi: 10.1007/s10350-008-9328-y. Epub 2008 May 16. Review. — View Citation
Mouw TJ, King C, Ashcraft JH, Valentino JD, DiPasco PJ, Al-Kasspooles M. Routine splenic flexure mobilization may increase compliance with pathological quality metrics in patients undergoing low anterior resection. Colorectal Dis. 2019 Jan;21(1):23-29. do — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Anastomotic Leakage Rate | The rate of symptomatic and asymptomatic colorectal anastomotic leakage | 4-6 weeks | |
| Secondary | Operating time | The duration of surgical procedure | 1 day | |
| Secondary | Intraoperative complications rate | The rate of complications during surgery | 1 day | |
| Secondary | Splenic flexure mobilization rate | The rate of splenic flexure mobilization in Low tie group | 1 day | |
| Secondary | Conversion rate | The rate of conversion from laparoscopic or robotic approach to open approach | 1 day | |
| Secondary | IMA architectonics | The incidence of left colic artery, first, second and third sigmoid arteries | 1 day | |
| Secondary | The length of IMA trunk | the length of inferior mesenteric artery trunk based on preoperative CT-scans and intraoperative findings | 1 day | |
| Secondary | Early postoperative complications rate | The rate of complications in first 30 days after surgery | 30 days | |
| Secondary | Specimen morphometry | The gross dimensions of resected specimen: length, the distal and proximal resection margins distance, vascular pedicle length | 30 days | |
| Secondary | Positive Apical Lymph Nodes Rate | The rate of metastatic lymph nodes found in the area of paraaortic lymph node dissection | 30 days | |
| Secondary | Complications of defunctioning stoma | Any complications of defunctioning stoma | 3 month | |
| Secondary | The postoperative hospital stay | the number of days from the first day after operation to discharge | 1 month |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
| Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
| Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
| Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
| Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
| Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
| Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
| Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
| Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
| Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
| Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
| Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A |